Search

Ali Aminian, Director of Bariatric and Metabolic Institute

Merck Sharp & Dohme LLC and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Assistance Publique Hopitaux De Marseille, Institut National de la Santé Et de la Recherche Médicale, France, Centre National de la Recherche Scientifique, France, Collège de France, University of Paris 5 - Rene Descartes, Pierre and Marie Curie University, University Paris 7 - Denis Diderot, and Aix Marseille Université

Marco Aurélio Santo, Principal investigator

Anton Cheng, Dr Anton Cheng

Bjørn Hoe, Medical Doctor, PhD student, Prinicipal Investigator

AstraZeneca and Eli Lilly and Company

Celestino Sardu, MD, MSc, PhD

Celestino Sardu, MD, MSc, PHD

AstraZeneca and Eli Lilly and Company

Celestino Sardu, principal investigator

Drug Safety and Effectiveness Network, Canada and Canadian Institutes of Health Research (CIHR)

Drug Safety and Effectiveness Network, Canada and Canadian Institutes of Health Research (CIHR)

Drug Safety and Effectiveness Network, Canada and Canadian Institutes of Health Research (CIHR)

Merck Sharp & Dohme LLC and Manfredi Tesauro, Associate Professor of Internal Medicine

University of Copenhagen, Steno Diabetes Center Copenhagen, and Signe H Østoft, MD, MD

Kyuzi Kamoi, MD

Kyuzi Kamoi, Investigator

University of Copenhagen